© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Posted 18th February 2020

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Discover Why the Leaders in Cell Therapy are Expanding with Title21 Health Solutions
Title21

Top Blood and Marrow Transplant and Immunotherapy programs depend on Title21 Health Solution’s (Title21) technology to manage the patient, product and process data from collection to infusion. From reporting to analytics, Title21 provides all the critical data at your fingertips so the right person has the right data at the right time to make the right decisions. This allows Medical Technologists, Technical and Medical Directors to focus on higher-value work, and ultimately the patient, rather than chasing down paperwork and people.

Earlier this year, Title21 was selected as the Most Outstanding Cell Therapy Software Provider for 2019 by AI’s Global Excellence Award. We had a chance to catch up with Lynn Fischer, the CEO at Title21 who provided us with a detailed insight into the award-winning software provider.

Since their inception, Tile21’s Cloud and onpremise software manages critical patient, product and process data for cell and gene therapy, immunotherapy and regenerative medicine to ensure quality, compliance and traceability. Programs that implement Title21 solutions find they can scale more effectively to treat more patients and can also translate products more quickly and efficiently from bench to bedside, delivering the latest innovative therapies to patients faster and more safely.

Title21 has served FDA-regulated life science companies for many years with quality management software, so Title21’s experience has been of great service to the cell therapy segment. “Our technology is extremely flexible due to its configurability on the front end. That means that we can maintain a single code base while meeting each cancer center or cell manufacturers’ specific requirements.”

“Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day.”

“At Title21, we partner with the largest and top-rated cancer hospitals – placing the patient first. One of our greatest testimonials we hear often is that our customers want us to continue to solve more of their challenges with our technology. They ask Title21 to help provide solutions through technology to increase the quality, safety and efficiency of their programs.” Current Title21 customers have a strong influence on the technology roadmap to add value to patient therapeutic care and quality. Analytics and business intelligence are also important and play a significant role in the future of developing new cures and protocols more quickly and efficiently. Cell and gene therapy is a dynamic market and the protocols are changing rapidly as they are improved and refined.

Moving forward, the future looks bright for the team at Title21 as they continue to provide exceptional services and award-winning solutions to hospitals and biotech firms. “Our passion is to serve the many patients and their families who face life-threatening diseases by supporting the leading healthcare institutions and biotech companies with powerful tools that help them deliver innovative treatments to their patients. Every team member at Title21 is dedicated to supporting the lifesaving work that health care providers do each and every day” remarks Fischer.

Bringing the interview to a close, Lynn signs off by revealing the exciting plans which lie in the pipeline for the business, which includes their ambitions to further expand the business in the years to come, especially with the advancements in immunotherapy technology.

Categories: Innovation


You Might Also Like
Read Full PostRead - Eye Icon
TelOne Signs Contract Extension with Avanti Communications
Strategy
23/04/2015TelOne Signs Contract Extension with Avanti Communications

Avanti Communications announced that TelOne, the Zimbabwean national telco, has signed an immediate extension to its major connectivity contract.

Read Full PostRead - Eye Icon
Enhancing Education
News
10/02/2023Enhancing Education

Award-winning Chatsworth Schools entered the private schools group market in 2018 with a passion for schools as learning communities and a commitment to excellence.

Read Full PostRead - Eye Icon
Is Gold A Promising Retirement Investment?
Finance
13/02/2023Is Gold A Promising Retirement Investment?

Retirement investments are essential for your later days, especially when you can no longer generate regular income like you used to.

Read Full PostRead - Eye Icon
The Role of Legal Expertise in Business Succession Planning
News
28/11/2024The Role of Legal Expertise in Business Succession Planning

Transitioning ownership represents one of the most significant challenges facing Australian business owners. Business succession planning lawyers provide critical guidance in navigating this complex process, helping protect your company’s future and ensu

Read Full PostRead - Eye Icon
Leasinvest Real Estate Sell Office Building in Kiem for EUR6.3m
Finance
25/03/2015Leasinvest Real Estate Sell Office Building in Kiem for EUR6.3m

On 16 March 2015, Leasinvest RealEstate sold the office building Kiem located rue Kiem in Strassen in the Grand Duchy of Luxembourg to a private investor for an amount of € 6.3 million (excluding costs), which corresponds to the fair value.

Read Full PostRead - Eye Icon
Effective Strategies for Real Estate Investment
News
19/09/2022Effective Strategies for Real Estate Investment

What are your long-term financial goals? Do you want to have enough retirement savings to stop working sooner than most? Are you hoping to make more money now so that your family will be more comfortable in the years to come? Whatever your motivation is for br

Read Full PostRead - Eye Icon
Can Blockchain And AI Work Together?
News
26/04/2022Can Blockchain And AI Work Together?

Can Blockchain And AI Work Together? There is a lot of buzz around the potential for blockchain and AI to work together. Some people believe that this could be the beginning of a whole new era of innovation, while others are skeptical. We will explore the rela

Read Full PostRead - Eye Icon
How Corporate Social Responsibility Can Prevent Workplace Accidents: A Legal Perspective
News
30/08/2024How Corporate Social Responsibility Can Prevent Workplace Accidents: A Legal Perspective

Corporate social responsibility (CSR) is fundamental to a company’s long-term relationship with its employees, the communities it operates in, and the protection of the environment. The role of CSR in preventing workplace accidents is increasingly being

Read Full PostRead - Eye Icon
Make Platform Payments Your Superpower
Innovation
06/12/2022Make Platform Payments Your Superpower

Vertical market software is particularly niche, and it should be tailored to each business – as well as across every industry.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow